MMedication Read More Lilly cuts price for obesity drug ZepboundDecember 1, 2025 Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
MMedication Read More Ozempic Prices Lowered After Trump DealNovember 17, 2025 Topline Novo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment…
MMedication Read More Novo cuts Wegovy prices, Zepbound cost also coming downNovember 17, 2025 Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients…
HHealth care Read More Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants’ Stocks?November 17, 2025 Don’t look now, but the costs of America’s beloved weight loss drugs are about to come down. Way…
HHealth care Read More Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity ManagementNovember 13, 2025 Mangoceuticals, Inc. Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”),…
MMedication Read More Eli Lilly, Tan France launch Zepbound ‘Changing the Thread’November 10, 2025 New innovative campaign weaves science and storytelling to help reframe obesity as a chronic disease INDIANAPOLIS, Nov. 10,…
MMedication Read More Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharmaNovember 10, 2025 New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
MMedication Read More Dr. Oz made a stunning estimate after Trump’s obesity drug deals: ’135 billion’ pounds?!November 8, 2025 Dr. Mehmet Oz was front and center Thursday as President Donald Trump unveiled a new deal with two…
HHealth care Read More Mark Cuban Praises TrumpRx Deal With Eli Lilly, Novo NordiskNovember 7, 2025 When President Trump told an audience in October that he hoped to cut the cost of Ozempic down…
HHealth care Read More Is Eli Lilly a Millionaire Maker?November 5, 2025 Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…
MMedication Read More Massive sales for weight loss drugs spur Eli Lilly’s Q3October 31, 2025 As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn…
MMedication Read More Eli Lilly says weight-loss pill a candidate for speedy approval under new US programOctober 31, 2025 By Mrinalika Roy and Patrick Wingrove (Reuters) -Eli Lilly said on Thursday its experimental weight-loss pill met most…